Martínez, S.N. et al. 2024. Safety and Immunogenicity of a PHH-1V Booster Dose after Different Prime Vaccination Schemes against Covid-19: Phase III Clinical Trial Final Results Up To One Year. Archives of Clinical and Biomedical Research. 8, 4 (Aug. 2024), 326–342.